First-in-Human Single Ascending and Multiple Dose of GLPG0778
Clinical trial NCT01278108 · COMPLETED
Trial details
- NCT number
- NCT01278108
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2011-02-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.